Munich Reinsurance Co Stock Corp in Munich Lowers Stake in HCA Healthcare, Inc. $HCA

Munich Reinsurance Co Stock Corp in Munich decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.8% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,866 shares of the company’s stock after selling 2,379 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich’s holdings in HCA Healthcare were worth $10,348,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. State Street Corp grew its holdings in HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors boosted its position in shares of HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after acquiring an additional 40,086 shares during the last quarter. Geode Capital Management LLC lifted its stake in HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank purchased a new position in shares of HCA Healthcare during the fourth quarter valued at about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HCA shares. Deutsche Bank Aktiengesellschaft reduced their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Argus reduced their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Oppenheimer dropped their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a report on Tuesday. Finally, Royal Bank Of Canada cut their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $497.14.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $409.98 on Thursday. The firm has a market cap of $90.95 billion, a PE ratio of 14.10, a price-to-earnings-growth ratio of 1.34 and a beta of 1.12. The firm’s 50 day simple moving average is $398.58 and its 200-day simple moving average is $461.22. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 earnings per share. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Negative Sentiment: Barclays reaffirmed its equal weight rating but lowered its price target sharply to $427 from $496, signaling reduced expectations for HCA Healthcare’s near-term stock performance. Benzinga
• Negative Sentiment: Cantor Fitzgerald cut its price target on HCA Healthcare to $525 from $588, reflecting a more cautious stance even while keeping an overweight rating. Benzinga
• Neutral Sentiment: Options-market activity is drawing attention because traders appear to be positioning for a larger move in HCA Healthcare stock, but the headline does not confirm a clear directional catalyst. Zacks
• Neutral Sentiment: Commentary around HCA’s post-earnings valuation and hold/buy-sell debate adds uncertainty, but it mainly reinforces that investors are reassessing the stock after recent results. MSN
• Positive Sentiment: Longer-term bullish pieces highlight HCA Healthcare’s capacity-expansion strategy, ongoing revenue and profit growth, and sizable buyback capacity, which support the investment case over time. Zacks
• Positive Sentiment: Seeking Alpha argued that HCA remains attractively priced despite recent underperformance, citing improving fundamentals, rising revenue and profitability, and ongoing shareholder returns. Seeking Alpha

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.